Check · Environmental · EMF In review

Does everyday EMF from phones, Wi-Fi and 5G cause cancer and serious harm?

Claim attributed to EMF-protection product sellers and fear-based wellness influencers , The people who push the strong version of this claim are usually selling the remedy: anti-radiation phone cases, shielding stickers and patches, pendants, and "EMF-blocking" fabrics, blankets and clothing, or affiliate-marketing them. The fear is the sales engine. They did not generate the evidence they cite; they lean on the IARC "Group 2B" label and a handful of contested case-control and animal studies, usually stripped of their stated limitations. The FTC took enforcement action against sellers of cell-phone "radiation protection" products in 2002 for false and unsubstantiated claims, and consumer guidance notes such shields can be useless or even prompt a phone to emit more power.

Verdict Unsupported
Evidence grade B Moderate certainty

The strong claim has been tested, not merely left untested, and it fails. The largest and least-biased human studies, including a prospective cohort built to defeat recall bias, find no link between everyday phone, Wi-Fi or 5G exposure and brain tumours, and population incidence has not risen as the technology saturated daily life. Genuine uncertainty survives for very long-term heavy use, childhood exposure, and the newer 5G bands, but uncertainty about small undetected effects is not evidence for the definite harm the sellers assert.

It blocks a signal it was never shown to block, against a cancer risk the best human evidence cannot find, sold by the people who profit from the fear.

The theory

What it’s supposed to target

  • Non-ionizing radiofrequency
  • Tissue heating (thermal)
  • Oxidative stress (claimed)
  • Blood-brain barrier (claimed)

Phones and Wi-Fi emit non-ionizing radiofrequency energy. The only firmly established biological effect is thermal: enough RF warms tissue, which is what safety limits are built around. The harm theory proposes non-thermal mechanisms instead, that weak RF fields cause oxidative stress, calcium-channel changes or a leaky blood-brain barrier at exposures far too low to heat anything.

The thermal pathway is real and is why limits exist; the non-thermal mechanisms are the crux of the fear and remain unestablished, with no consistent, reproducible route and large reviews finding no clear harm at everyday exposures. Crucially, non-ionizing RF lacks the energy to break DNA bonds the way ionizing radiation does. A real but bounded thermal mechanism, versus a hypothesized non-thermal one the evidence has not borne out.

Mechanism is theory, not proof. A plausible pathway explains why something might work, not whether it does. The verdict rests on the evidence below, not the elegance of the theory.

The claim

What would have to be true

There would need to be a biological mechanism by which everyday-intensity, non-ionizing RF causes cancer. HOLDS AGAINST THE CLAIM: RF photons are far too low-energy to damage DNA directly; the only established mechanism is tissue heating, and consumer devices sit far below the threshold where heating matters.

Heating from phones, Wi-Fi and 5G would have to reach harmful levels. HOLDS AGAINST: ICNIRP's adverse-effect threshold is a whole-body average around 6 W/kg, corresponding to a 1 degree C core-temperature rise; everyday exposure produces only negligible heating.

Heavy and long-term users would have to show elevated brain-tumour risk. HOLDS AGAINST: the prospective COSMOS cohort found rate ratios near 1.0 even in the heaviest users and those with 15-plus years of use; large register and cohort studies agree.

If everyday RF caused brain tumours at the magnitude alarming studies imply, population incidence should have risen as phones became universal. HOLDS AGAINST: US glioma incidence was flat for two decades and malignant brain-tumour incidence has slightly declined, despite a roughly 1,200-fold rise in subscriptions.

The one genuine positive signal (heart schwannomas in male rats) would have to translate to human exposure. DOES NOT HOLD: that effect appeared only in male rats under whole-body exposure for 9 hours a day for two years at intensities at or above the human limit, was absent in female rats and mice, and the program itself warns it should not be extrapolated to human phone use.

The link that does NOT close: small effects from very long latency, childhood exposure, or the newest 5G bands cannot be fully ruled out. This is genuine residual uncertainty, but it cannot support a definite, present-tense harm claim.

The evidence

What the evidence actually shows

The mechanism: non-ionizing, and the only proven harm is heat

Radiofrequency EMF from phones, Wi-Fi and 5G is non-ionizing. Its photon energy is orders of magnitude too low to break chemical bonds or directly damage DNA, which is what separates it from X-rays and UV. Across decades of research the only established mechanism by which RF interacts with tissue is dielectric heating.

International exposure limits are built around that single mechanism. The ICNIRP 2020 guidelines (covering 100 kHz to 300 GHz) set their restrictions so that tissue heating stays trivial: the operational adverse-effect threshold is a whole-body average SAR of about 6 W/kg, which corresponds to a 1 degree C rise in body-core temperature, and ICNIRP then adopts the more conservative 4 W/kg as its basic restriction. Consumer devices operate far below this and produce only negligible heating. 5G uses the same RF region of the spectrum studied for decades; its higher bands penetrate less deeply into tissue, not more.

No reproducible non-thermal mechanism by which everyday-intensity RF would cause cancer has been established. That is the mainstream position. It is fair to note it is not unanimous, claimed oxidative-stress and calcium-channel effects are argued in the bioeffects literature, so the honest phrasing is *not established and not reproducibly demonstrated* rather than *proven impossible*.

The human evidence converges on no effect, including the test built to defeat recall bias

The strongest single piece of recent human evidence is the prospective COSMOS cohort (264,574 participants, median 7.1 years of follow-up, many with 15-plus years of use). Because exposure was recorded at baseline and combined with operator records *before* any diagnosis, COSMOS is immune to the recall bias that plausibly generated earlier positive case-control signals. It found no association: glioma hazard ratio 1.00 per 100 cumulative call-hours (95% CI 0.98-1.02), and for the heaviest users HR 1.07 (95% CI 0.62-1.86) and for 15-plus years of use HR 0.97 (95% CI 0.62-1.52). This is the most direct test of the heavy-user hypothesis that actually drives the harm claim, and it came back null.

The WHO-commissioned 2024 systematic review (Karipidis et al., 63 articles, 22 countries) reached moderate-certainty conclusions that mobile-phone use *likely does not* increase glioma, meningioma, acoustic neuroma, pituitary or salivary-gland tumours, nor paediatric brain tumours, and that fixed transmitters and base stations *likely do not* raise childhood leukaemia. The NCI summarises the field plainly: "the evidence to date suggests that cell phone use does not cause brain or other kinds of cancer in humans."

Two large studies are often cited as decisive but deserve a caveat. The UK Million Women Study (776,156 women, ~14 years) reported an ever-versus-never relative risk of 0.97 (95% CI 0.90-1.04), and the Danish nationwide cohort (358,403 subscribers) reported a glioma rate ratio of 1.04 (95% CI 0.85-1.26) at 10-plus years and 0.98 at 13-plus years, with meningioma at 0.90 (95% CI 0.57-1.42). Both are reassuring, but both are *exposure-limited*: the Million Women cohort had heavy attrition and very few heavy users, and the Danish study used phone *subscription* as a crude proxy that misclassifies the heaviest corporate users. They support the conclusion; they are not the load-bearing disconfirmation. COSMOS is.

The population reality check

If everyday RF caused brain tumours at the magnitude the most alarming studies imply, incidence should have climbed as phones went from rare to universal. It did not. Little et al. (2012) found US glioma incidence essentially flat from 1992-2008 (-0.02%/year, 95% CI -0.28% to 0.25%). That flat trend was compatible with the small risks suggested by INTERPHONE, but incompatible with the much larger Swedish (Hardell) estimates, which would have predicted rates roughly 40-45% higher than observed.

An updated SEER analysis (2000-2021) extends this picture into the smartphone era: while mobile subscriptions rose roughly 1,200-fold, malignant brain-tumour incidence in adolescents and adults declined slightly (annual percentage change -0.6), and incidence in the temporal lobe, the region most exposed during a call, showed no significant change (APC -0.06). Ecological data cannot prove the absence of a tiny effect, but Hardell-sized risks are simply not visible in two decades of population data.

The disconfirming evidence, handled honestly

The single strongest positive result is the US National Toxicology Program two-year rat-and-mouse bioassay, an independent, US-government-funded study. It reported "clear evidence" of malignant heart schwannomas in male rats, plus some evidence of brain glioma and adrenal tumours in male rats. This is a real signal and should not be waved away.

But the reason it does not establish the human claim is exposure, not disproof. The animals received whole-body exposure for about 9 hours a day for two years at intensities at or above the human local-tissue limit (up to roughly 6 times the maximum human exposure). The clear effect appeared only in male rats; findings in female rats and in mice were ambiguous. NTP states the results "should not be directly extrapolated to human cell phone usage," and ICNIRP judged the study's limitations precluded conclusions about human carcinogenicity. There is also a documented survival confound: exposed male rats outlived the controls, leaving more time to develop late-life tumours.

On the other side of the ledger sits the positive human literature, chiefly the Hardell case-control series (ipsilateral heavy-use glioma odds ratio around 2.3) and a 2024 competing meta-analysis (Moon et al.) that, reading the same studies through a different exposure proxy, reported elevated risk in the heaviest callers. This is a genuine, live, competing-evidence dispute, not a footnote. What tips the balance is study design: the positive signal is concentrated in retrospective case-control studies, the design most vulnerable to recall and selection bias, and a 2024 simulation showed those biases can manufacture exactly that spurious heavy-user signal. The bias-resistant prospective design (COSMOS) and the population trends do not reproduce it.

Evidence quality

Studies, graded, and who paid

Mechanism: everyday RF causes cancer through some non-thermal pathway B Moderate certainty

Non-ionizing RF cannot break chemical bonds; the only established interaction is heating, and at consumer levels that heating is negligible. No reproducible non-thermal carcinogenic mechanism has been established, though some bioeffect pathways remain debated rather than closed.

Outcome: mobile-phone use raises brain-tumour risk at normal exposure B Moderate certainty

Large cohorts and a recall-bias-resistant prospective study (COSMOS) find rate ratios sitting on 1.0, including for the heaviest users and 15-plus years of use.

Population signal: a real effect would show in incidence trends B Moderate certainty

US glioma incidence was flat 1992-2008 and malignant brain-tumour incidence declined slightly through 2021 while subscriptions rose roughly 1,200-fold; large claimed risks are incompatible with this.

Residual uncertainty: very long latency, childhood, and new 5G bands C Low certainty

Follow-up rarely exceeds 15-20 years and few studies cover 5G mid/high frequencies; a small undetected effect cannot be excluded. This supports caution, not the strong harm claim.

Cited studies with type, size, funding/conflicts, and limitations.
# Study Type Size Funding / COI Key limitations
63 Karipidis 2024, WHO-commissioned systematic review Systematic review / meta-analysis of human observational studies 63 studies, 22 countries, 119 exposure-outcome pairs Independent Commissioned and part-funded by WHO; further support from NZ Ministry of Health, Istituto Superiore di Sanita, ARPANSA. No telecom-industry funding stated. Built on observational studies that can bound but never prove zero risk; a published ICBE-EMF critique disputes the conclusions.
1 COSMOS prospective cohort (Feychting/Elwood 2024) Prospective cohort 264,574 participants; median 7.1-year follow-up Independent World Health Organization and UK Medical Research Council; authors declared no competing financial interests. Median follow-up still only ~7 years; relies on calibrated self-report plus operator data. Strength: exposure recorded before diagnosis, so immune to recall bias.
2 UK Million Women Study (Schuz 2022) Prospective cohort 776,156 women; 3,268 brain-tumour cases; ~14-year follow-up Independent UK Medical Research Council and Cancer Research UK; authors declared no conflict of interest. Heavy attrition and early/coarse exposure assessment; very few heavy users, so weak for testing the heavy-use hypothesis.
3 Danish nationwide cohort (Frei 2011) Nationwide register-based cohort 358,403 subscribers; 3.8M person-years; 10,729 CNS-tumour cases Independent Danish Strategic Research Council; Swiss National Science Foundation; no competing interests declared. Subscription used as exposure proxy misclassifies the heaviest (corporate) users, biasing toward the null.
4 Little 2012, US glioma incidence vs phone uptake Ecological / incidence-trend US SEER population, 1992-2008 Independent NIH Intramural Research Program; National Cancer Institute. Ecological design cannot detect a small individual-level effect; compatible with small INTERPHONE risks, incompatible with large Hardell risks.
5 Zhang & Muscat 2025, SEER brain-tumour trends 2000-2021 Ecological / incidence-trend 20,325 adult and 2,372 paediatric CNS malignancies (SEER 22) Independent Stated as not funded by any institution; authors declare no conflicts of interest. Ecological design; cannot establish individual causation, only test plausibility of large effects against real trends.
6 NTP 2-year rat/mouse RF bioassay Animal carcinogenicity bioassay ~3,000 rats and mice across exposure groups Independent US Government (NIH/NIEHS). No industry funding. Whole-body exposure 9 hrs/day for 2 years at or above human SAR limits; clear effect only in male rats, ambiguous in females and mice; survival confound; NTP says do not extrapolate to humans.
7 IARC 2011 Group 2B classification (Press Release N 208) Hazard classification / expert working-group statement 31 scientists, 14 countries, reviewing hundreds of articles Independent IARC (WHO agency); no commercial funding. A hazard label about strength of evidence, not a risk estimate; driven largely by one heavy-user finding (~40% raised glioma OR); the group did not quantify risk.

The pattern here is the reverse of the usual Caveat finding: the reassuring evidence is the independent evidence. The Million Women Study (UK MRC and Cancer Research UK), the Danish cohort (Danish and Swiss public funds), Little et al. (NIH/NCI), the SEER 2000-2021 update (unfunded), the WHO-commissioned review, and COSMOS (WHO and UK MRC) all report null or near-null results, and none relied on telecom-industry money. The strongest positive signal, the NTP rat study, was also independent (NIH/NIEHS) and is reported here in full. The split that actually predicts the result is methodological, not financial: the positive human signal lives almost entirely in retrospective case-control designs vulnerable to recall and selection bias, while the prospective design built to defeat that bias (COSMOS) and the population-trend data do not reproduce it. Allegations of industry influence on ICNIRP exist, but they come largely from the EMF-concern advocacy world and, even if granted, do not touch these independent null findings.

Stay neutral

Unproven ≠ disproven

Definitive proof of "no effect" is structurally impossible. Epidemiology can place an upper bound on a risk but can never demonstrate exactly zero, and IARC itself notes the possibility of a very small risk can never be excluded. Brain tumours are rare and slow-growing, so detecting a small long-latency effect needs enormous cohorts and decades of follow-up, and the technology keeps changing faster than long-term studies mature: today's 5G smartphone is not the 1990s analog phone most long-term data describe. Exposure is now near-universal, which leaves few truly unexposed controls and makes recall-based studies fragile.

This is exactly the case, though, where "unproven is not disproven" does NOT rescue the claim. The strong claim has not been left untested; it has been tested hard, including with the bias-resistant prospective design and with real-world incidence trends, and it has failed. Residual uncertainty about a small, undetected effect at very long latency, in children, or at the newest 5G frequencies is real and justifies continued research and reasonable precaution. It does not justify the definite, present-tense assertion that everyday EMF *does* cause cancer and serious harm.

The gap

Where claim and evidence diverge

The claim says everyday phone, Wi-Fi and 5G exposure *causes* cancer and serious harm now, in the general population. The evidence says the opposite for the part that has been measured: no mechanism at everyday intensities beyond trivial heating, near-null risk in the best human studies including the heaviest users, and population incidence that has not risen (and has slightly fallen) as exposure became universal.

Where the claim and the evidence genuinely diverge from certainty is narrow and specific: lifetime heavy use beyond 15-20 years, exposure beginning in childhood, and the newest 5G mid/high bands remain less studied. The sellers' claim treats that narrow, residual uncertainty as if it were proof of broad, established harm. It is not. The IARC "Group 2B / possibly carcinogenic" label is the linchpin of the marketing, and it is routinely misread: 2B means only that a positive association was seen but chance, bias or confounding could not be ruled out, it carries no risk estimate, and the same category contains aloe vera extract and pickled vegetables.

Follow the funding

The money trail

EMF-protection product sellers profit directly from the fear this claim creates: anti-radiation phone cases, shielding stickers and patches, pendants and medallions, and "EMF-blocking" fabrics, blankets and clothing.

In 2002 the FTC charged Stock Value 1, Inc. and Comstar Communications, Inc. with false and unsubstantiated claims that their products block up to 97-99% of the radiation emitted by cell phones.

FTC consumer guidance separately notes there is no scientific proof such shields meaningfully reduce exposure; shields that cover only part of the phone are ineffective, and by interfering with the signal a "phony shield" can make the phone draw more power and possibly emit more radiation.

Independent product testing (e.g. by the Good Housekeeping Institute) found that shields marketed as reducing RF exposure did not do so.

Wellness and influencer ecosystems monetise the claim through affiliate links, sponsored "EMF detox" content and product lines, with the unproven cancer-fear framing as the core sales driver.

For balance: critics allege the telecom industry has influenced exposure limits set by bodies like ICNIRP. That allegation is contested and unproven, and it does not bear on the independently funded null findings that anchor this check.

Bottom line

The honest read

The honest read is that the everyday-exposure cancer claim has been examined about as thoroughly as an environmental question can be, and it does not hold up. The physics gives no plausible mechanism at these intensities beyond negligible heating; the best human study, a prospective cohort designed specifically to defeat the recall bias that produced earlier scares, finds no excess risk even in the heaviest, longest-term users; and the disease itself has not become more common as phones became universal. When the most direct, least-biased test of a claim comes back null and the population data agree, "Unsupported" is the accurate verdict, not "Unproven."

This is a real verdict, not a dismissal. A genuine positive signal exists in male rats at exposures far above anything a person experiences, and a vocal scientific minority disputes the WHO review's methods and reads the heavy-user case-control data as positive. We took those seriously and they do not survive the prospective and population evidence. What remains legitimately open, very long latency, childhood exposure, and the newest 5G bands, is worth continued study and modest caution. None of it supports buying a shielding sticker, and the sellers of those stickers are the ones who profit when you believe otherwise.

Falsifiable

What would change this verdict

A large prospective cohort or pooled analysis with 15-plus years of well-characterised heavy use (ideally extending COSMOS) showing a clear, dose-responsive excess of glioma or acoustic neuroma that survives correction for bias.

A reproducible, independently replicated non-thermal mechanism by which everyday-intensity RF damages DNA or initiates tumours, demonstrated at exposure levels people actually encounter.

A sustained, unambiguous rise in brain-tumour incidence (especially temporal-lobe and ipsilateral tumours) tracking the smartphone and 5G era that cannot be explained by improved detection or coding changes.

Receipts

Sources

  1. Feychting M, Elwood M, Roosli M, et al. Mobile phone use and brain tumour risk - COSMOS, a prospective cohort study. Environment International. 2024;185:108552. PMID 38458118.
  2. Schuz J, et al. (UK Million Women Study). Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study. J Natl Cancer Inst. 2022;114(5):704-711. PMID 35350069.
  3. Frei P, Poulsen AH, Johansen C, Olsen JH, Steding-Jessen M, Schuz J. Use of mobile phones and risk of brain tumours: update of Danish cohort study. BMJ. 2011;343:d6387. PMID 22016439.
  4. Little MP, Rajaraman P, Curtis RE, et al. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ. 2012;344:e1147. PMID 22403263.
  5. Zhang L, Muscat JE. Trends in Malignant and Benign Brain Tumor Incidence and Mobile Phone Use in the U.S. (2000-2021): A SEER-Based Study. Int J Environ Res Public Health. 2025;22(6):933.
  6. National Toxicology Program (NIH/NIEHS). Cell Phone Radio Frequency Radiation - study findings and conclusions (clear evidence of heart schwannomas in male rats; do-not-extrapolate caution).
  7. IARC (WHO). Press Release N 208: IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans (Group 2B). 31 May 2011.
  8. Karipidis K, Baaken D, Loney T, et al. The effect of exposure to radiofrequency fields on cancer risk in the general and working population: A systematic review... Part I. Environ Int. 2024;191:108983. PMID 39241333.
  9. World Health Organization. Radiation: 5G mobile networks and health (Questions & Answers). 27 Feb 2020.
  10. ICNIRP. Guidelines for limiting exposure to electromagnetic fields (100 kHz to 300 GHz). Health Phys. 2020;118(5):483-524.
  11. National Cancer Institute. Cell Phones and Cancer Risk Fact Sheet.
  12. Federal Trade Commission. FTC Charges Sellers of Cell Phone Radiation Protection Patches With Making False Claims. Press release, Feb 2002.
Common questions

People also ask

Do mobile phones cause brain tumours?
The best evidence says no at normal exposure. Large cohorts and the recall-bias-resistant prospective COSMOS study find risk ratios sitting on 1.0, including for the heaviest users and 15-plus years of use.
Is 5G dangerous to your health?
The everyday-exposure harm claim is unsupported, though the newest 5G mid and high bands are less studied. Follow-up rarely exceeds 15 to 20 years, so a small undetected effect cannot be excluded, which supports modest caution, not the strong harm claim.
What does the IARC Group 2B label for RF actually mean?
Group 2B means only that a positive association was seen but chance, bias or confounding could not be ruled out. It carries no risk estimate, and the same category includes aloe vera extract and pickled vegetables, so it is routinely misread.
Do EMF protection cases and stickers work?
No. FTC guidance notes there is no scientific proof such shields meaningfully reduce exposure, and independent testing found marketed shields did not. Partial-coverage shields are ineffective and can make a phone draw more power.
Verified 2026-06-07 · awaiting final human sign-off Independent · No industry money

Caveat is journalism, not medical advice. We check public claims against published evidence; we don’t diagnose, treat, or tell you what to take.